291 related articles for article (PubMed ID: 22441649)
21. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
22. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
Toure OA; Kone PL; Coulibaly MA; Ako BA; Gbessi EA; Coulibaly B; N' Guessan LT; Koffi D; Beourou S; Soumahoro A; Bassinka I; Nogbou M; Swa T; Gba B; Esmel B; Bokossa EM
Parasit Vectors; 2014 Nov; 7():495. PubMed ID: 25410760
[TBL] [Abstract][Full Text] [Related]
23. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Tutu EO; Lawson B; Browne E
Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
[TBL] [Abstract][Full Text] [Related]
27. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO
Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818
[TBL] [Abstract][Full Text] [Related]
28. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
[TBL] [Abstract][Full Text] [Related]
29. Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania.
Protas J; Tarimo D; Moshiro C
BMC Res Notes; 2016 Jun; 9():318. PubMed ID: 27328717
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
Kayiba NK; Yobi DM; Tchakounang VRK; Mvumbi DM; Kabututu PZ; Devleesschauwer B; Mukomena ES; DeMol P; Hayette MP; Mvumbi GL; Rosas-Aguirre A; Lusamba PD; Speybroeck N
Infect Genet Evol; 2021 Oct; 94():105009. PubMed ID: 34284138
[TBL] [Abstract][Full Text] [Related]
31. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
[TBL] [Abstract][Full Text] [Related]
32. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
[TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
[TBL] [Abstract][Full Text] [Related]
34. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Desai M; Gutman J; Taylor SM; Wiegand RE; Khairallah C; Kayentao K; Ouma P; Coulibaly SO; Kalilani L; Mace KE; Arinaitwe E; Mathanga DP; Doumbo O; Otieno K; Edgar D; Chaluluka E; Kamuliwo M; Ades V; Skarbinski J; Shi YP; Magnussen P; Meshnick S; Ter Kuile FO
Clin Infect Dis; 2016 Feb; 62(3):323-333. PubMed ID: 26486699
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
[TBL] [Abstract][Full Text] [Related]
37. The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya.
Ouma PO; Van Eijk AM; Hamel MJ; Sikuku E; Odhiambo F; Munguti K; Ayisi JG; Kager PA; Slutsker L
Trop Med Int Health; 2007 Aug; 12(8):953-61. PubMed ID: 17697090
[TBL] [Abstract][Full Text] [Related]
38. Antimalarials during pregnancy: a cost-effectiveness analysis.
Schultz LJ; Steketee RW; Chitsulo L; Wirima JJ
Bull World Health Organ; 1995; 73(2):207-14. PubMed ID: 7743592
[TBL] [Abstract][Full Text] [Related]
39. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
40. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
